COVID-19 pill rollout stymied by shortages as omicron rages

Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.

Related Keywords

New York ,United States ,Texas ,Washington ,White House ,District Of Columbia ,California ,Maryland ,Pennsylvania ,Michigan ,Desert Hot Springs ,Americans ,Greg Schrank ,Jeff Zients ,Mary Bassett ,Erin Mccreary ,Bobby Calvan ,Craige Campbell ,Myron Cohen ,David Eggert ,Glaxosmithkline ,Pfizer ,University Of Maryland Medical Center Dr ,University Of Pittsburgh Medical Center ,Washington Times ,Drug Administration ,University Of North Carolina ,Pittsburgh Medical ,North Carolina ,Health Commissioner ,Maryland Medical Center ,B Health Medical Pharma ,B Pfizer ,